Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systematic Literature Review
100%
Epidemiology
50%
Meta-analysis
50%
Granulomatosis with Polyangiitis
50%
Treatment Burden
50%
Literature Review Analysis
50%
Economic Productivity
50%
Europe
50%
Obesity
50%
Confidence Interval
18%
Incidence Prevalence
18%
Body Mass Index
14%
Work Outcomes
14%
Embase
13%
MEDLINE
13%
Ovid
12%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
7%
European Context
7%
Economic Burden
7%
Unemployment
7%
Sickness Absence
7%
Healthy Body
7%
Long-term Benefit
7%
Work Performance
7%
Sickness Presenteeism
7%
People with Obesity
7%
Sickness Leave
7%
Chronic Absenteeism
7%
Epistemonikos
7%
Population Health
7%
Random-effects Meta-analysis
6%
Nervous System
6%
Unmet Needs
6%
Rare Diseases
6%
Frequentist
6%
Clinical Manifestations
6%
Lung
6%
Asthma
6%
Constitutional Symptoms
6%
Patient Experience
6%
Treatment-related Morbidity
6%
Treatment-related Mortality
6%
Mortality Burden
6%
Treatment Resources
5%
Burden of Illness Study
5%
Hypertension in Adults
5%
Nursing and Health Professions
Systematic Review
100%
Diseases
56%
Health Economics
50%
Critical Appraisal
50%
Resistant Hypertension
50%
Hypertension
50%
Body Mass
50%
Embase
31%
Obesity
25%
Checklist
12%
Economic Evaluation
12%
Quality of Life
12%
Cost Effectiveness Analysis
12%
Blood Pressure
12%
Kidney Denervation
6%
Clinical Trial
6%
Healthcare System
6%
Quality Control
6%
Underserved Population
6%
Resource Allocation
6%
Cost-Minimization Analysis
6%
Systolic Blood Pressure
6%
Medline
6%
Health Outcomes
6%
Economic and Social Development
6%
Data Extraction
6%
Meta Analysis
6%
Cost Utility Analysis
6%
Medicine and Dentistry
Systematic Review
100%
Diseases
56%
Eosinophilic Granulomatosis with Polyangiitis
50%
Cohort Effect
50%
Meta-Analysis
50%
Body Mass Index
50%
Obesity
25%
Job Performance
25%
Population Health
25%
Prevalence
18%
Arteritic Anterior Ischemic Optic Neuropathy
7%
Patient Experience
6%
Lung
6%
Rare Disease
6%
Constitutional Symptoms
6%
Nervous System
6%
Asthma
6%
